Koers OWC Pharmaceutical Research Corp. Other OTC
Aandelen
OWCP
US67109N1081
Geavanceerde medische apparatuur & technologie
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 15,37 mln. 14,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -4 mln. -3,68 mln. | Nettowinst (verlies) 2018 | -10 mln. -9,2 mln. | EV/omzet 2017 | - |
Nettoliquiditeiten 2017 | 971K 892K | Nettoliquiditeiten 2018 | 3,46 mln. 3,19 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-14,5
x | K/w-verhouding 2018 |
-1,21
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 16-06-14 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 02-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 25-06-20 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,69% | 2,95 mld. | |
+19,36% | 1,88 mld. | |
-1,05% | 1,63 mld. | |
+33,96% | 1,34 mld. | |
-16,83% | 959 mln. | |
-21,96% | 888 mln. | |
+7,07% | 842 mln. | |
-26,88% | 623 mln. | |
+10,85% | 513 mln. |